0000000000223090

AUTHOR

Ignacio González-garcía

0000-0003-3663-3259

showing 5 related works from this author

In vitro–in vivocorrelations: general concepts, methodologies and regulatory applications

2015

The major objective of in vitro-in vivo correlations is to be able to use in vitro data to predict in vivo performance serving as a surrogate for an in vivo bioavailability test and to support biowaivers. Therefore, the aims of this review are: (i) to clarify the factors involved during bio-predictive dissolution method development; and (ii) the elements that may affect the mathematical analysis in order to exploit all information available. This article covers the basic aspects of dissolution media and apparatus used in the development of in vivo predictive dissolution methods, including the latest proposals in this field as well as the summary of the mathematical methods for establishing …

PharmacologyChemistryChemistry PharmaceuticalOrganic ChemistryBiological AvailabilityPharmaceutical SciencePharmacologyIn vitroBioavailabilityIVIVCSolubilityIn vivoDrug DiscoveryAnimalsHumansIn vitro in vivoDrug Development and Industrial Pharmacy
researchProduct

Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers.

2014

Abstract Introduction In vitro models with high predictive ability have been revealed as strong tools for pharmaceutical industry. However, the variability in permeability estimations complicates the comparison and combination of data from different laboratories and it makes necessary the careful validation of the model and the continuous suitability demonstration. The adequate standardization of pre-experimental, experimental and post-experimental factors might help to reduce the inter- and intra-laboratory variability in permeability values. Methods The objective of this paper is the evaluation of the effect of passage number, experimental protocol, time after seeding and calculation meth…

PharmacologyCell membrane permeabilityCell Membrane PermeabilityChemistryMadin Darby canine kidney cellCell Culture TechniquesNanotechnologyBiological Transportengineering.materialToxicologyMadin Darby Canine Kidney CellsRhodaminechemistry.chemical_compoundPermeability (earth sciences)DogsCoatingParacellular transportMonolayerengineeringBiophysicsAnimalsHumansCaco-2 CellsCells CulturedJournal of pharmacological and toxicological methods
researchProduct

Towards patient stratification and treatment in the autoimmune disease lupus erythematosus using a systems pharmacology approach

2015

Drug development in Systemic Lupus Erythematosus (SLE) has been hindered by poor translation from successful preclinical experiments to clinical efficacy. This lack of success has been attributed to the high heterogeneity of SLE patients and to the lack of understanding of disease physiopathology. Modelling approaches could be useful for supporting the identification of targets, biomarkers and patient subpopulations with differential response to drugs. However, the use of traditional quantitative models based on differential equations is not justifiable in a sparse data situation. Boolean networks models are less demanding on the required data to be implemented and can provide insights into…

0301 basic medicineDrugSystems biologymedia_common.quotation_subjectPharmaceutical ScienceAntineoplastic AgentsDiseaseBioinformaticsAutoimmune Diseases03 medical and health sciencesmedicineAnimalsCluster AnalysisHumansLupus Erythematosus SystemicComputer Simulationmedia_commonAutoimmune diseaseLupus erythematosusbusiness.industrySystems Biologymedicine.diseaseTreatment Outcome030104 developmental biologyDrug developmentPharmacology ClinicalbusinessBiological networkSystems pharmacologyEuropean Journal of Pharmaceutical Sciences
researchProduct

Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation.

2018

Regulatory guidelines recommend that, when a level A IVIVC is established, dissolution specification should be established using averaged data and the maximum difference between AUC and Cmax between the reference and test formulations cannot be greater than 20%. However, averaging data assumes a loss of information and may reflect a bias in the results. The objective of the current work is to present a new approach to establish dissolution specifications using a new methodology (individual approach) instead of average data (classical approach). Different scenarios were established based on the relationship between in vitro-in vivo dissolution rate coefficient using a level A IVIVC of a cont…

In vitro dissolutionCmaxPharmaceutical Science02 engineering and technologyBioequivalence021001 nanoscience & nanotechnology030226 pharmacology & pharmacyControlled releaseModels Biological03 medical and health sciencesDrug Liberation0302 clinical medicineIVIVCTherapeutic EquivalencyDelayed-Action PreparationsMaximum differenceRange (statistics)Computer Simulation0210 nano-technologyBiological systemDissolutionMonte Carlo MethodMathematicsTabletsEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Population pharmacokinetic model of lithium and drug compliance assessment.

2016

Population pharmacokinetic analysis of lithium during therapeutic drug monitoring and drug compliance assessment was performed in 54 patients and 246 plasma concentrations levels were included in this study. Patients received several treatment cycles (1-9) and one plasma concentration measurement for each patient was obtained always before starting next cycle (pre-dose) at steady state. Data were analysed using the population approach with NONMEM version 7.2. Lithium measurements were described using a two-compartment model (CL/F=0.41Lh-1, V1/F=15.3L, Q/F=0.61Lh-1, and V2/F = 15.8L) and the most significant covariate on lithium CL was found to be creatinine clearance (reference model). Lith…

OncologyAdultMalemedicine.medical_specialtyBipolar DisorderPopulationPopulationchemistry.chemical_elementRenal functionBiological AvailabilityLithium030226 pharmacology & pharmacy03 medical and health sciencesYoung Adult0302 clinical medicinePharmacokineticsAntimanic AgentsInternal medicineStatisticsCovariateMedicineHumansPharmacology (medical)educationBiological PsychiatryPharmacologyeducation.field_of_studyModels Statisticalmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryMiddle AgedMarkov ChainsNONMEMBioavailabilityPsychiatry and Mental healthNeurologychemistryTherapeutic drug monitoringLithium CompoundsPatient ComplianceLithiumFemaleNeurology (clinical)Drug Monitoringbusiness030217 neurology & neurosurgeryEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct